8-K ·Filed Jun 9, 2026

VREOF

Vireo Growth Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed3mo ago SEC0001104659-26-071886
8-K material event: Items 4.01
Actionable Insight • Neutral

Auditor changes without disagreements are routine governance updates. Monitor the next 10-Q for any audit-related disclosures or shifts in internal control opinions. No immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
VREOF ▼ -15.97% at T+60d
NEUTRAL call ✗ call lost -15.97% · α vs SPY -22.82% · entry $12.90 → $10.84
Entry anchored
Jun 9, 2026
via day open
T+1d
-2.87%
call -2.87% · α -4.57%
$12.53
settled 4mo ago
T+5d
-12.60%
call -12.60% · α -14.74%
$11.28
settled 4mo ago
T+20d
-23.88%
call -23.88% · α -27.77%
$9.82
settled 3mo ago
T+60d
-15.97%
call -15.97% · α -22.82%
$10.84
settled 29d ago

Price Chart

Loading chart...

Executive Summary

Vireo Growth Inc. dismissed Davidson & Company LLP as independent auditor and appointed BDO USA, P.C. effective June 5, 2026. The change was approved by the Audit Committee and Board, with no disagreements or reportable events reported between the company and Davidson. The press release frames this as a 'right-sizing' move to support an M&A growth strategy, but the shift from a Canadian firm to BDO is neutral-to-slightly-positive from a governance perspective, not a material catalyst.

Key Facts

  • Dismissed Davidson & Company LLP as auditor on June 5, 2026.
  • Appointed BDO USA, P.C. as new independent auditor for FY ending Dec. 31, 2026.
  • No disagreements or reportable events occurred between company and Davidson during fiscal years 2024-2025 or subsequent interim period.
  • CEO cited fast-paced M&A growth strategy as rationale for switching to a larger firm with global capabilities.
  • Press release issued June 9, 2026, filed as Exhibit 99.1.

Financial Impact

Not specified

Risk Factors

  • Auditor change could signal unknown issues, but no disagreements were disclosed.
  • Execution risk on M&A strategy cited by management is forward-looking and unquantified.

Market Snapshot

Exchange
OTC
Analyst Consensus
0% bullish (9 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-071886
Document: tm2617168d1_ex99-1.htm0001104659-26-071886
Document: tm2617168d1_ex16-1.htm0001104659-26-071886
Document: 0001104659-26-071886-index-headers.html0001104659-26-071886
Document: 0001104659-26-071886-index.html0001104659-26-071886
Document: 0001104659-26-071886.txt0001104659-26-071886
13 reports for VREOF
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +18.71%Jun 18, 2026
Filters
Rows
Reports for VREOF — sortable, filterable
TypeNow
Aug 18, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$10.97 $12.11▲ +10.39%▲ +11.91%$9.61 (−12.40%)
Aug 11, 2026
7w ago
8-K
MIXED ★ 6/10
$10.64 $12.12▲ +13.91%▲ +14.97%$9.61 (−9.68%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$10.01 $10.84▲ +8.29%▲ +7.69%$9.61 (−4.00%)
Jul 30, 2026
9w ago
8-K
NEUTRAL ★ 5/10
$9.44 $10.60▲ +12.29%▲ +9.30%$9.61 (+1.80%)
Jul 27, 2026
9w ago
8-K
NEUTRAL ★ 5/10
$9.70 $10.89▲ +12.27%▲ +8.97%$9.61 (−0.93%)
Jun 18, 2026
15w ago
8-K
BULLISH ★ 6/10
$10.42 $9.80▼ −5.95%▼ −5.64%$9.61 (−7.77%)
Jun 11, 2026
16w ago
8-K
MIXED ★ 5/10
$12.46 $10.02▼ −19.58%▼ −20.84%$9.61 (−22.87%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$12.90 $9.82▼ −23.88%▼ −27.77%$9.61 (−25.50%)
May 29, 2026
18w ago
8-K
MIXED ★ 6/10
$13.05 $9.99▼ −23.47%▼ −22.17%$9.61 (−26.34%)
May 12, 2026
20w ago
8-K
BEARISH ★ 7/10
$12.09 $12.90▼ −6.70%▼ −8.43%$9.61 (+20.51%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (38h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access